This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slawik, M. Articles by Beuschlein, F. Search for Related Content PubMed PubMed Citation Articles by Slawik, M. Articles by Beuschlein, F.

Characterization of an Adrenocorticotropin (ACTH) Receptor Promoter Polymorphism Leading to Decreased Adrenal Responsiveness to ACTH

Division of Endocrinology and Diabetes (M.Sl., N.R., O.Z., C.M.-G., M.St., A.K., M.R., F.B.), Department of Internal Medicine II, University Hospital Freiburg, D-79106 Freiburg, Germany; and Institute of Pharmacology, Ruprecht Karls University (C.M.-G.), D-69120 Heidelberg, Germany

Address all correspondence and requests for reprints to: Martin Reincke, M.D., Medizinische Klinik Innenstedt, Ludwig-Maximilians-Universitaet Muenchen, Ziemsenstrasse 1, D-80336 Munich, Germany. E-mail: Martin.Reincke{at}med.uni-muenchen.de.

The ACTH receptor has a pivotal role in the regulation of adrenal cortisol secretion. Here, we describe a polymorphism within the transcription initiation site of the ACTH receptor promoter altering the consensus sequence from CTC to CCC. The prevalence of the polymorphism in 1266 unrelated healthy men was 80.2% for CTC/CTC, 19.0% for CTC/CCC, and 0.8% for CCC/CCC, respectively. In vitro studies using luciferase assays demonstrated a lower basal (CCC, 73 ± 4%; CTC, 100 ± 5%; P = 0.02) and forskolin-stimulated (CCC, 143 ± 13%; CTC, 194 ± 15%; P = 0.0008) promoter activity in the CCC construct compared with CTC. The clinical significance of the in vitro findings was investigated by a 6-h ACTH stimulation test with increasing ACTH_1–24 doses in normal subjects, demonstrating a blunted cortisol response in CCC/CCC subjects compared with CTC/CTC individuals (area under the curve, 12176 ± 966; 16334 ± 1051 nmol/liter·min; P < 0.03). Accordingly, after CRH stimulation, subjects with CCC/CCC showed a higher ACTH/cortisol ratio (P < 0.05) suggesting a decreased adrenal responsiveness to endogenous ACTH. In conclusion, we describe an ACTH receptor promoter polymorphism that results in a lower promoter activity in vitro and is associated with a lower cortisol secretion to prolonged ACTH stimulation in vivo. This polymorphism might influence cortisol homeostasis under stress conditions.

This work was supported by a grant from Deutsche Forschungsgemeinschaft.

M.Sl. and N.R. contributed equally to this work.

Abbreviations: CRE, cAMP-responsive element; CV, coefficient of variation; HPA, hypothalamus-pituitary-adrenal; PKA, protein kinase A; POMC, proopiomelanocortin.

This article has been cited by other articles:

				Yixin Su and J. C. Rose The Impact of ACTH Receptor Knockdown on Fetal and Adult Ovine Adrenocortical Cell Function Reproductive Sciences, April 1, 2008; 15(3): 253 - 262. [Abstract] [PDF]

				K. Wingenfeld, C. Heim, I. Schmidt, D. Wagner, G. Meinlschmidt, and D. H. Hellhammer HPA Axis Reactivity and Lymphocyte Glucocorticoid Sensitivity in Fibromyalgia Syndrome and Chronic Pelvic Pain Psychosom Med, January 1, 2008; 70(1): 65 - 72. [Abstract] [Full Text] [PDF]

				A. M. Rasmusson, M. R. Picciotto, and S. Krishnan-Sarin Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review J Psychopharmacol, September 1, 2006; 20(5): 693 - 707. [Abstract] [PDF]

				N. Reisch, M. Slawik, O. Zwermann, F. Beuschlein, and M. Reincke Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion Eur. J. Endocrinol., November 1, 2005; 153(5): 711 - 715. [Abstract] [Full Text] [PDF]

				M. J. Betz, I. Shapiro, M. Fassnacht, S. Hahner, M. Reincke, F. Beuschlein, and for the German Austrian Adrenal Network Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Suppress Adrenocortical Tumor Cell Proliferation and Induce Differentiation J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3886 - 3896. [Abstract] [Full Text] [PDF]

				L.-A. Li and P.-W. Wang PCB126 Induces Differential Changes in Androgen, Cortisol, and Aldosterone Biosynthesis in Human Adrenocortical H295R Cells Toxicol. Sci., May 1, 2005; 85(1): 530 - 540. [Abstract] [Full Text] [PDF]

				W. Wu, H. Kamma, M. Fujiwara, Y. Yano, H. Satoh, H. Hara, T. Yashiro, E. Ueno, and Y. Aiyoshi Altered Expression Patterns of Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in the Adrenal Cortex J. Histochem. Cytochem., April 1, 2005; 53(4): 487 - 495. [Abstract] [Full Text] [PDF]

				W. J. Kovacs Editorial: Toward Understanding Variation in Responsiveness to Hormones J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3129 - 3130. [Full Text] [PDF]